Investors

Egetis is an innovative, unique, and integrated pharmaceutical drug development company, focusing on projects in late-stage development for treatment of serious rare/niche diseases with significant unmet medical needs in the orphan drug segment

Presentations

Aktiedagen (in Swedish)

May 4

Redeye Orphan Drugs

April 28, 2021

Corporate presentation, slides

April 26, 2021

Interview with Dr Thomas Lönngren, nominated CoB and CEO Nicklas Westerholm

April 1, 2021

Egetis – Corporate Presentation

March 5, 2021

Interview with CEO Nicklas Westerholm at Redeye

February 18, 2021

Interview with CEO Nicklas Westerholm in Pareto TV

February 1, 2021

Egetis Therapeutics – Corporate presentation

December, 2020

Company investor and analyst presentation – acquisition of RTT

October 5, 2020

Acquisition of Rare Thyroid Therapeutics – Interview at Redeye

October 5, 2020

Egetis and RTT agree to join forces

October 5, 2020

Pareto Healthcare Seminar – Company presentation

September 2, 2020

Pareto Helthcare Seminar – interview with Egetis’s CEO

September 2, 2020

Interview with Egetis’s CEO at Redeye

August 20, 2020

Company presentation, June 2020

June 11, 2020

Interview with Egetis’s CEO at Penser

4 juni, 2020

The Penser Corporate Day

June 4, 2020

Redeye Growth Day

June 2, 2020

ABGSC Life Science Summit

May 26, 2020

Pareto interview with Egetis’s CEO

April 23, 2020

Presentation AGM 2020

April 23, 2020

Webcast concerning the POLAR program

April 6, 2020

Telephone conference – Egetis provides update on the clinical POLAR program

March 2. 2020

Redeye Interview with Egetis’s CEO

February 18, 2020

Telephone conference – Egetis provides update on the clinical POLAR program, clinical hold in the US

January 23, 2020

Company presentation, January 2020

January 10, 2020

Redeye Interview with Egetis’s CEO

December, 2019

Aktiespararnas Healthcare direkt (in Swedish):
Egetis vd om Pledox förutsättningar i fas 3-studien POLAR samt marknadspotentialen

November 14, 2019

Company presentation, November 2019

November 7, 2019

Interview with Egetis’s CEO about the third quarter

October 23, 2019

Web cast CMD

Capital Markets Day – presentation

Mar 26, 2019

Calendar and upcoming reports

May 6, 2021
Erik Penser bank- Commercialization of pharmaceuticals

May 25, 2021
ABGSC Life Science Summit

Show more events

Share

Twitter
LinkedIn

Contact us

Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden

Phone: +46 8 679 72 10

E-mail: info@egetis.com